Cancer patient in $16k hit to stay alive

A NSW leukaemia patient has told of his family's distress trying to raise $16,000 every three weeks for each dose ...

Read more →

Call for feedback: anti-VEGF drugs for retinal conditions

CADTH is pleased to invite all interested parties to provide feedback on the list of included studies being considered for ...

Read more →

AbbVie files New Drug Submission to Health Canada for its investigational, all-oral, interferon-free therapy for the treatment of hepatitis C

AbbVie filed a New Drug Submission (NDS) to Health Canada seeking approval for the company's investigational, all-oral, interferon-free regimen for the ...

Read more →

Melanoma treatment among 50 new medicines added to PBS list

Fifty new and amended medicines have been added to the Pharmaceutical Benefits Scheme. Health Minister Peter Dutton says it means ...
Read more →

Promoting competition key to improving patients’ access to high cost medicines

[:content [\8 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \space \P \H \A \R \M \A \C \space \h \a \s \space \a \n \n \o \u \n \c \e \d \space \i \t \s \space \i \n \t \e \n \t \i \o \n \space \t \o \space \t \e \s \t \space \o \u \t \space \a \space \c \o \n \t \e \s \t \a \b \l \e \space \f \u \n \d \space \f \o \r \space \h \i \g \h \space \c \o \s \t \space \m \e \d \i \c \i \n \e \s \space \f \o \r " ..."]]
Read more →

The Yukon to fund treatment with Aubagio for relapsing-remitting multiple sclerosis

Genzyme, a sanofi company, announced today that the Yukon Pharmaceutical Programs have included Aubagio (teriflunomide) 14 mg on the territorial drug ...

Read more →

David Cameron’s flagship Cancer Drugs Fund ‘is a waste of NHS cash’

A furious political row is set to erupt this week over a key part of David Cameron’s health service strategy. ...

Read more →

Summary of the agenda for the PBAC July 2014 meeting

[:content [\1 \space \M \a \y \space \2 \0 \1 \4 \space \- \T \h \e \space \P \B \A \C \space \w \i \l \l \space \c \o \n \s \i \d \e \r \space \5 \0 \space \s \u \b \m \i \s \s \i \o \n \s \space \( \2 \7 \space \m \a \j \o \r \space \& \space \2 \3 \space \m \i \n \o \r \) \space \a \t \space \i \t \s \n \e \x \t \space \s \c \h \e \d \u \l \e \d \space \m \e \e \t \i \n \g \space \i \n \space \J \u \l \y \. \  " ..."]]
Read more →

AbbVie receives Health Canada approval of Holkira Pak for the treatment of chronic genotype 1 hepatitis C

AbbVie receives Health Canada approval for Holkira Pak (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the ...

Read more →

SMC - forthcoming submissions

Below a list of forthcoming submissions that have recently been added to the SMC's programme. Information in relation to the drug ...

Read more →

Québec government covers Lemtrada (alemtuzumab) for MS patients

Genzyme, a Sanofi company, announced today that Québec's Institut national d'excellence en santé et services sociaux (INESSS) has recommended that Lemtrada (alemtuzumab) 12 ...

Read more →

Pharmac continues expanding medicines within budget

[:content [\5 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \T \h \e \space \a \n \n \u \a \l \space \r \e \v \i \e \w \space \o \f \space \N \e \w \space \Z \e \a \l \a \n \d \' \s \space \d \r \u \g \- \b \u \y \i \n \g \space \a \g \e \n \c \y \space \P \h \a \r \m \a \c \space \s \h \o \w \s \space \i \t \space \i \s \space \p \a \y \i \n \g \space \s \u \b \s \t \a \n \t \i \a \l \l \y \space \l \e \s \s \space \f \o \r \space \s \o \m \e " ..."]]
Read more →

NICE is moving onward according to Sir Michael Rawlins

[:content [\F \o \u \r \space \k \e \y \space \f \a \c \t \o \r \s \space \h \a \v \e \space \a \l \l \o \w \e \d \space \t \h \e \space \U \. \K \. \space \N \a \t \i \o \n \a \l \space \I \n \s \t \i \t \u \t \e \space \f \o \r \space \H \e \a \l \t \h \space \a \n \d \space \C \a \r \e \space \E \x \c \e \l \l \e \n \c \e \space \( \N \I \C \E \) \space \t \o \space \i \m \p \r \o \v \e \space \c \a \r \e \space \i \n \space \t \h \e " ..."]]
Read more →

New drug for pancreatic cancer turned down

The NHS drugs rationing body has ruled that a drug for pancreatic cancer that can extend lives of patients is ...

Read more →

Australian Statistics on Medicines 2011

[:content [\1 \7 \space \A \p \r \i \l \space \2 \0 \1 \4 \space \- \  \T \h \e \  \2 \0 \1 \1 \space \e \d \i \t \i \o \n \space \o \f \space \A \u \s \t \r \a \l \i \a \n \space \S \t \a \t \i \s \t \i \c \s \space \o \n \space \M \e \d \i \c \i \n \e \s \  \i \s \space \n \o \w \space \a \v \a \i \l \a \b \l \e \space \o \n \space \t \h \e \space \P \B \S \space \w \e \b \s \i \t \e \  " ..."]]
Read more →